What Is HGH and Why Does It Decline?
Human Growth Hormone (HGH) is produced by the pituitary gland and regulates cell growth, metabolism, body composition and organ function. HGH is released in pulses — the largest of which occurs during deep sleep. Peak HGH production occurs in adolescence and early adulthood; from the late 20s, production declines progressively at approximately 14% per decade.
By the mid-40s, HGH levels may be 50–60% below peak. This decline is associated with increased body fat (particularly visceral fat), reduced muscle mass, lower energy levels, slower recovery from exercise and changes in skin quality. The decline in growth hormone activity is measured clinically through IGF-1 (Insulin-Like Growth Factor 1) — the primary downstream marker of HGH activity.
Prescription HGH injections are available for diagnosed growth hormone deficiency but carry significant cost, inconvenience and risk profiles. Natural HGH releasers take a fundamentally different approach — providing nutritional precursors (primarily amino acids) that the pituitary gland uses in its own HGH synthesis, supporting the body's natural production rather than introducing exogenous hormone.
What the GenF20 Plus® Clinical Study Actually Shows
A double-blind, placebo-controlled clinical study on GenF20 Plus® was conducted to evaluate its effects on serum IGF-1 levels. Key findings:
- Statistically significant increases in serum IGF-1 versus placebo group
- Improvements were measured over the study period in adults aged 35–65
- The study used the complete GenF20 Plus® formula — not just individual ingredients
- IGF-1 elevation was measurable within the study period
This is significant because most "HGH support" supplements cite ingredient-level research — studies on individual amino acids like L-Arginine — and extrapolate to the finished product. GenF20 Plus® has a study on the actual product, measuring the actual downstream marker of HGH activity. This is a meaningfully higher level of evidence.
How the Dual Delivery System Works
GenF20 Plus® uses two complementary delivery mechanisms.
Enteric-coated tablets: The tablet coating is designed to resist dissolution in stomach acid and break down in the higher-pH environment of the small intestine — where absorption of amino acid compounds is significantly more efficient. This ensures the amino acid HGH precursors reach their primary absorption site at full potency.
Alpha GPC oral spray: Alpha-Glycerylphosphorylcholine in spray form allows sublingual (under-tongue) absorption — bypassing gastrointestinal transit entirely for rapid entry into the bloodstream. Alpha GPC has published evidence of stimulating growth hormone secretion. The spray is designed for administration between meals when natural GH pulsing occurs.
Who is GenF20 Plus® Most Appropriate For?
GenF20 Plus® is most relevant for adults in their 30s, 40s and beyond experiencing the physiological changes associated with declining HGH. It is formulated for both men and women. The effects are most pronounced in individuals with the greatest degree of natural decline — younger adults with physiologically normal HGH levels are unlikely to experience significant benefit.
It is not a substitute for adequate sleep — 70–80% of daily HGH release occurs during deep sleep phases. GenF20 Plus® supports and amplifies natural HGH production but cannot compensate for chronic sleep deprivation. Optimal results occur when supplementation is combined with consistent, quality sleep of 7–9 hours per night.